Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 19;13(12):e077117.
doi: 10.1136/bmjopen-2023-077117.

Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study)

Collaborators, Affiliations

Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study)

Josie Henley et al. BMJ Open. .

Abstract

Objective: To explore and model factors affecting antibiotic prescribing decision-making early in the pandemic.

Design: Semistructured qualitative interview study.

Setting: National Health Service (NHS) trusts/health boards in England and Wales.

Participants: Clinicians from NHS trusts/health boards in England and Wales.

Method: Individual semistructured interviews were conducted with clinicians in six NHS trusts/health boards in England and Wales as part of the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients study, a wider study that included statistical analysis of procalcitonin (PCT) use in hospitals during the first wave of the pandemic. Thematic analysis was used to identify key factors influencing antibiotic prescribing decisions for patients with COVID-19 pneumonia during the first wave of the pandemic (March to May 2020), including how much influence PCT test results had on these decisions.

Results: During the first wave of the pandemic, recommendations to prescribe antibiotics for patients with COVID-19 pneumonia were based on concerns about secondary bacterial infections. However, as clinicians gained more experience with COVID-19, they reported increasing confidence in their ability to distinguish between symptoms and signs caused by SARS-CoV-2 viral infection alone, and secondary bacterial infections. Antibiotic prescribing decisions were influenced by factors such as clinician experience, confidence, senior support, situational factors and organisational influences. A decision-making model was developed.

Conclusion: This study provides insight into the decision-making process around antibiotic prescribing for patients with COVID-19 pneumonia during the first wave of the pandemic. The importance of clinician experience and of senior review of decisions as factors in optimising antibiotic stewardship is highlighted. In addition, situational and organisational factors were identified that could be optimised. The model presented in the study can be used as a tool to aid understanding of the complexity of the decision-making process around antibiotic prescribing and planning antimicrobial stewardship support in the context of a pandemic.

Trial registration number: ISRCTN66682918.

Keywords: COVID-19; infection control; infectious diseases.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors (with the exception of RH) and members of the PEACH consortium received funding from NIHR COVID Learning and Recovery Call programme (NIHR132254) for the PEACH Study and for the delivery of this manuscript. ET-J, JE, LB-H, PP and WM (main authors) and ST (consortium) all received funding from NIHR-HTA programme for delivery of the PRONTO trial (NIHR17/136/13). EC, ET-J, PP and LB-H received funding from NIHR for the BATCH trial (15/188/42). EC, ET-J and PP received funding from MRC-NIHR EME for contribution to the PRECISE study (NIHR129960). PH received funding from Abbot Laboratories for attending the European Network for Antimicrobial Stewardship in Point of Care. PH has also previously held post as Vice Chancellor for British Society for Antimicrobial Chemotherapy (BSAC) and is currently a committee member.

Figures

Figure 1
Figure 1
The complex factors which influence decisions to prescribe antibiotics. The blue boxes indicate the combination of factors contributing to the likelihood of prescribing antibiotics. The three main factors are: the acuity of the illness (how sick they are), the vulnerability of the patient to infection (age, immunosuppression, risk factors) and the likelihood of bacterial infection (based on clinical signs, laboratory tests and radiology). Other factors: clinician experience, confidence and support; situational factors; laboratory tests; organisational influences. The directional colour scale (orange) indicates the likelihood for prescribing antibiotics, with darker shaded areas weighted towards a higher likelihood of prescribing, and areas of lighter shading towards lower likelihood of prescribing. *Situational factors include time of day, family/patient pressure to prescribe antibiotics, etc. (The question of how much impact family/patient pressure had on decision-making was presented to clinicians during the interviews. The majority expressed that they were senior and confident enough to ignore pressure to prescribe, which could be expressed during telephone calls from relatives. However, they might take patient wishes into consideration in terms of intolerances or preferences against particular antibiotics.) **Organisational factors include staffing levels, busyness of emergency department (ED), availability of laboratory test results in real time, etc.

References

    1. Langford BJ, So M, Raybardhan S, et al. . Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clinical Microbiology and Infection 2021;27:520–31. 10.1016/j.cmi.2020.12.018 - DOI - PMC - PubMed
    1. Llewelyn MJ, Budgell EP, Laskawiec-Szkonter M, et al. . Antibiotic review kit for hospitals (ARK-hospital): a stepped-wedge cluster-randomised controlled trial. Lancet Infect Dis 2023;23:207–21. 10.1016/S1473-3099(22)00508-4 - DOI - PubMed
    1. Kubin CJ, Loo AS, Cheng J, et al. . Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: challenges and opportunities. Am J Health Syst Pharm 2021;78:743–50. 10.1093/ajhp/zxaa419 - DOI - PMC - PubMed
    1. Borek AJ, Maitland K, McLeod M, et al. . Impact of the COVID-19 pandemic on community antibiotic prescribing and stewardship: a qualitative interview study with general practitioners in England. Antibiotics (Basel) 2021;10:1531. 10.3390/antibiotics10121531 - DOI - PMC - PubMed
    1. Stoichitoiu LE, Pinte L, Ceasovschih A, et al. . In-hospital antibiotic use for COVID-19: facts and rationales assessed through a mixed-methods study. J Clin Med 2022;11:3194. 10.3390/jcm11113194 - DOI - PMC - PubMed

Publication types

Associated data